A preclinical canine model for composite tissue transplantation

Journal of Reconstructive Microsurgery

Volumn 26, Issue 3, 2010, Pages 201-207

  Mathes, David W ^a   Noland, Marie ^a   Graves, Scott ^a   Schlenker, Robert ^a   Miwongtum, Tiffany ^a   Storb, Rainer ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Canine; Composite tissue allograft; Large animal model; Muscle rejection; Skin rejection

Indexed keywords

LEUKOCYTE ANTIGEN;

ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BIOPSY TECHNIQUE; COMPOSITE GRAFT; DEEP INFERIOR EPIGASTRIC PERFORATOR FLAP; DOG; EPIGASTRIC ARTERY; EXPERIMENTAL MODEL; FREE TISSUE GRAFT; GRAFT PERFUSION; GRAFT REJECTION; ILIAC ARTERY; ILIAC VEIN; IMMUNOSUPPRESSIVE TREATMENT; MYOCUTANEOUS FLAP; NONHUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANASTOMOSIS, SURGICAL; ANIMALS; DOGS; EPIGASTRIC ARTERIES; GRAFT SURVIVAL; IMMUNOSUPPRESSION; MODELS, ANIMAL; RECTUS ABDOMINIS; SURGICAL FLAPS; TRANSPLANTATION, AUTOLOGOUS;

EID: 77749315077     PISSN: 0743684X     EISSN: 10988947     Source Type: Journal    
DOI: 10.1055/s-0030-1247717     Document Type: Article

References (34)

1. Siemionow M, Nasir S. Chimerism and bone marrow based therapies in transplantation. Microsurgery 2007 27 510-521
2. International Registry on Hand and Composite Tissue Transplantation. Available at: http://www.handregistry.com/page.asp?page=4 Accessed August 1, 2009
3. Lanzetta M, Petruzzo P, Dubernard J M. et al. Second report (19982006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol 2007 18 1-6
4. Whitaker I S., Duggan E M., Alloway R R. et al. Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons. J Plastic Reconstr Aesthet Surg 2008 61 481-492
5. Mihatsch M J., Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998 49 356-363
6. Philip A T., Gerson B. Toxicology and adverse effects of drugs used for immunosuppression in organ transplantation. Clin Lab Med 1998 18 755-765
7. Mele T S., Halloran P F. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000 47 215-245
8. Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 2007 30 861-881 (Pubitemid 47481442)
9. Fishman J A., Rubin R H. Infection in organ-transplant recipients. N Engl J Med 1998 338 1741-1751
10. Schneeberger S, Lucchina S, Lanzetta M et al. Cytomegalovirus-related complications in human hand transplantation. Transplantation 2005 80 441-447
11. Baumeister S, Kleist C, Döhler B, Bickert B, Germann G, Opelz G. Risks of allogeneic hand transplantation. Microsurgery 2004 24 98-103
12. Storb R, Yu C, Wagner J L. et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997 89 3048-3054
13. Yu C, Seidel K, Nash R A. et al. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 1998 91 2581-2587
14. Yu C, Storb R, Mathey B et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. Blood 1995 86 4376-4381
15. Storb R, Raff R F., Appelbaum F R. et al. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. Transplantation 1993 56 800-807
16. Storb R, Epstein R B., Rudolph R H., Thomas E D. Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation 1969 7 378-386
17. Storb R, Epstein R B., Graham T C., Thomas E D. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970 9 240-246
18. Wagner J L., Burnett R C., DeRose S A., Francisco L V., Storb R, Ostrander E A. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 1996 62 876-877
19. Wagner J L., Works J D., Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. Tissue Antigens 1998 52 397-401
20. World's first face and double-hand transplant patient dies in France. The Daily Telegraph June 16, 2009. Available at: http://www.dailytelegraph.com.au/ news/world/worlds-first-face-and-and-double-hand-transplant-patient-dies-in- france/story-e6frev00-1225736077918 Accessed August 15, 2009
21. Kirk A D. Crossing the bridge: large animal models in translational transplantation research. Immunol Rev 2003 196 176-196
22. Ikeguchi R, Sacks J M., Unadkat J V. et al. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Transplantation 2008 85 237-246
23. Demir Y, Ozmen S, Klimczak A, Mukherjee A L., Siemionow M. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg 2004 114 1790-1801
24. Blattman J N., Antia R, Sourdive D J. et al. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 2002 195 657-664
25. Siemionow M, Unal S. Strategies for tolerance induction in nonhuman primates. Ann Plast Surg 2005 55 545-553
26. Cendales L C., Xu H, Bacher J, Eckhaus M A., Kleiner D E., Kirk A D. Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. Transplantation 2005 80 1447-1454
27. Goldwyn R M., Beach P M., Feldman D, Wilson R E. Canine limb homotransplantation. Plast Reconstr Surg 1966 37 184-195
28. Wagner J L., Burnett R C., Storb R. Organization of the canine major histocompatibility complex: current perspectives. J Hered 1999 90 35-38
29. Ochiai T, Nagata M, Nakajima K et al. Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 1987 44 729-733
30. Storb R, Yu C, Wagner J L. et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997 89 3048-3054
31. Yu C, Seidel K, Nash R A. et al. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 1998 91 2581-2587
32. Storb R, Raff R F., Appelbaum F R. et al. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. Transplantation 1993 56 800-807
33. Luznik L, O'Donnell P V., Symons H J. et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008 14 641-650
34. Maris M B., Niederwieser D, Sandmaier B M. et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003 102 2021-2030